RT Book, Section A1 Bashore, Thomas M. A1 Granger, Christopher B. A1 Jackson, Kevin P. A1 Patel, Manesh R. A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1184696311 T1 Infectious Myocarditis T2 Current Medical Diagnosis & Treatment 2022 YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781264269389 LK accessmedicine.mhmedical.com/content.aspx?aid=1184696311 RD 2024/03/28 AB Key Clinical Updates in Infectious MyocarditisCOVID-19 myocarditis has been reported between 3% and 58% of infected people based on underlying myocardial risk and imaging.For COVID-19 related myocarditis, treatment is generally supportive.A 2020 review noted that of the attempted therapies, such as remdesivir, glucocorticoids, IL-6 inhibitors (tocilizumab), IVIG, and colchicine, only corticosteroids appeared to have any favorable effect on outcomes.